Revenue
EPS
EBIT
Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: JPY
Delta-Fly Pharma: Extraordinary Report
Oct 7 14:00
Sep 11 14:00
Delta-Fly Pharma: Supplementary materials for Q1 financial results for March 2025.
Aug 9 14:05
Delta-Fly Pharma: Short statement of financial results for Q1 in March 2025 (based on Japanese standards, non-consolidated).
Read more
No Data